A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
This protocol describes a technique for intracameral injection in rats using a central corneal incision and a long tunnel into the anterior chamber. This injection method minimizes the risk of inducing inadvertent tissue damage and thereby improves precision and reproducibility.
Intracameral injection is a standard administration routine in ophthalmology. The application of intracameral injection in rodents for research is challenging due to the limiting dimensions and anatomy of the eye, including the small aqueous humor volume, the lens curvature, and lens thickness. Potential damage during intracameral injections introduces adverse effects and experimental variability. This protocol describes a procedure for intracameral injection in rats, allowing precision and reproducibility.
Sprague-Dawley rats were used as experimental models. Since the lens position in rats protrudes into the anterior chamber, injecting from the periphery, as done in humans, is unfavorable. Therefore, an incision is created in the central corneal region using a 31 gauge 0.8 mm stiletto blade to form a self-sealing tunnel into the anterior chamber. An incision at an angle close to the flat allows to create a long tunnel, which minimizes the loss of aqueous humor and shallowing of the anterior chamber. A 34 gauge nanoneedle is inserted into the tunnel for injection. This enables penetration with minimal friction resistance and avoids touching the lens. Injection of trypan-blue allows visualization by slit microscopy the presence of the dye in the anterior chamber and exclude leakage. Bioavailability to the corneal endothelial layer is demonstrated by injection of Hoechst dye, which stained the nuclei of corneal endothelial cells after injection.
In conclusion, this protocol implements a procedure for accurate intracameral injection in rats. This procedure may be used for intracameral delivery of various drugs and compounds in experimental rat models, increasing the efficiency and reproducibility of ophthalmic research.
The bioavailability of compounds delivered by topical administration to the surface of the eye is greatly limited, typically <5%1. Compounds administered by eye drops are mainly eliminated by drainage, induced lacrimation, tear fluid turnover, and conjunctival absorption. In addition, the permeation of compounds through the ocular surface is highly restricted by the cornea-conjunctiva barrier1,2,3. The cornea is composed of three main layers: the outermost epithelium, the intermediate stroma, and the innermost endothelium. The superficial corn....
The experiments in the protocol were approved by the National Permit Committee - for animal science and comply with the ARVO Statement the use of animals in ophthalmic and vision research. Female Sprague-Dawley rats, aged 8-10 weeks, were used for the present study and were exposed to 12/12 h light-dark cycles. The animals were obtained from a commercial source (see Table of Materials).
1. Animal preparation
Sprague Dawley rats were intracamerally injected with 5 µL of trypan blue according to the protocol described above. Slit lamp examination immediately after injection demonstrated that the chamber was stained with trypan blue, indicating that the injected material reached the anterior chamber (Figure 3). Furthermore, the anterior chamber depth was intact, suggesting that the injection did not cause leakage of aqueous humor and shallowing of the chamber.
Pre-clinical research models should provide a controlled and reproducible environment to ensure the reliability and applicability of findings. In ophthalmology research, eye injection models are commonly used in diverse research aspects ranging from establishing disease models, testing new treatments, and assessing tissue reactions and potential adverse effects.
Intracameral injections serve as a common technique in experimental ophthalmology, facilitating the direct delivery of compounds to t.......
This research was supported by the Israel Science Foundation grants 2670/23 and 1304/20.
....Name | Company | Catalog Number | Comments |
Alizarin Red | Alpha Aesar | 042040.5 | |
Buprenorphine | Richter pharma | 102047 | |
Dexamethasone 0.1% | Fisher Pharmaceutical | 393102-0413 | |
Hamilton glass syringe 10 μL | Hamilton Co. | 721711 | |
Hoeschst | Merck | B2261 | |
Ketamine | Bremer pharma GMBH (medimarket) | 17889 | |
Ofloxacin 0.3% eye drops | Allergan | E92170 | |
Oxybuprocaine Hydrochloride 0.4% | Fisher Pharmaceutical | N/A | |
Pentobarbital sodium 200 mg/mL | CTS | N/A | |
Slit microscope | Haag-streit bern | b-90019115 | |
Sprague-Dawley Rats | Envigo | N/A | |
Stiletto blade 31 G 0.8 mm | Tecfen medical (skymed) | QKN2808 | |
Surgical microscope | Zeiss | OPMI-6 CFC | |
Trypan Blue | Sartorius | 03-102-1B | |
Xylazine | Eurovet Animal Health | 615648 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved